Curocell, Breaks Ground on ‘CAR-T Manufacturing GMP Facility’
- Thursday, December 23, 2021, 7:14
- Environment
- Add a comment
DAEJEON, South Korea, Dec. 23, 2021 Curocell, currently on Phaseâ… CAR-T Therapy clinical trial with CRC01 (anbalcabtagene autoleucel) has recently broken ground for the new CAR-T Center in Dungok Residential & Industrial Area in Daejeon International Science & Business Belt. The GMP…
About the Author
adminasapcorp has written 41555 stories on this site.